Development of an Automatic Measurement Method for CD8 and PD-1 Positive T Cells Using Image Analysis Software
Haruo Miyata1, Yasuto Akiyama2, Akira Iizuka1
1Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
Anticancer Research
|December 31, 2021
Summary
An automated imaging software method accurately measures tumor-infiltrating lymphocytes (TILs), aiding in evaluating cancer immunotherapy effectiveness. This tool simplifies assessing treatment responses for immune checkpoint blockade therapy.
Area of Science:
- Oncology
- Immunology
- Computational Pathology
Background:
- Immune checkpoint blockade (ICB) therapy has advanced cancer treatment.
- Accurate assessment of tumor-infiltrating lymphocytes (TILs) is crucial for evaluating ICB efficacy.
- Histological analysis of TILs requires efficient and reliable quantification methods.
Purpose of the Study:
- To develop and validate an automated imaging software-based method for measuring TILs.
- To compare the accuracy of automated TIL counting with manual counting methods.
- To establish a simple tool for evaluating cancer immunotherapy effects.
Main Methods:
- Formalin-fixed paraffin-embedded tissue sections from colorectal and gastric cancer patients were stained for CD8 and PD-1.
- An in-house algorithm and imaging analysis software were used to establish an automated TIL measurement method.
- Automated counts were compared against manual counting using Pearson correlation.
Main Results:
- Automated CD8+ T cell counting showed good correlation with manual counts (r=0.738).
- Initial PD-1+ T cell measurements showed discrepancies between automated and manual methods.
- Adjusting software parameters improved the correlation for PD-1+ T cell measurements (r=0.668).
Conclusions:
- Automated imaging software provides a simple and useful method for TIL status evaluation.
- This approach can aid in assessing the therapeutic effects of cancer immunotherapies.
- The developed tool supports the quantitative analysis of immune responses in tumors.


